Results 241 to 250 of about 142,808 (310)

MITF maintains genome stability in nonmelanocyte lineages

Molecular Oncology, EarlyView.
MITF is essential for melanocyte survival and acts as an oncogene in 10%–20% of melanomas. We show that MITF depletion causes genome instability in nonmelanocytic cells, leading to LATS2‐mediated P53 activation, cell cycle arrest, and apoptosis. This study highlights the role of MITF as a genome maintenance factor beyond the melanocyte lineage. Created
Drifa H. Gudmundsdottir, Adrián López García de Lomana, Thejus B. Venkatesh, Kritika Kirty, Snaevar Sigurdsson, Linda Vidarsdottir, Ramile Dilshat, Erla Sveinbjornsdottir, Snaedis Ragnarsdottir, Daniel H Magnusson, Maria R. Bustos, Eirikur Steingrimsson, Thorkell Gudjonsson, Stefan Sigurdsson   +13 more
wiley   +1 more source

Assessment of liver regeneration in living donor liver transplantation recipients using computed tomography volumetry-an institutional experience. [PDF]

Ann Hepatobiliary Pancreat Surg
Solanki S, Jayant A, Rawat KS, Das SAP, Nundy S, Mehta NN.   +5 more
europepmc   +1 more source

Right hepatic duct stenosis and leakage in right lobe graft living donor liver transplantation

, 2000
Fan, ST
core  

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

Molecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka, Wioleta Cieślik, Wojciech Płaziński, Katarzyna Stępnik, Anna Boguszewska‐Czubara, Elżbieta Kot, Robert Musioł, Mateusz Jasica, Anna Mrozek‐Wilczkiewicz, Katarzyna Malarz   +9 more
wiley   +1 more source

Non-HLA Genetics and Application to Living Donor Candidates. [PDF]

Curr Transplant Rep
Caliskan Y, Afsar B, Afsar RE, Varma C, Aygormez O, Lentine KL.   +5 more
europepmc   +1 more source

Human leukocyte antigen-incompatible living donor kidney transplantation after desensitization: experience from a major transplant centre in Mexico. [PDF]

Transpl Int
Reynoso de la Torre HL, Rojas-Campos E, Cerrillos-Gutiérrez JI, Evangelista-Carrillo LA, Banda-López A, Cruz-Landino M, Aguilar-Fletes LE, González-Correa LG, Alatorre-Moreno EV, Simancas-Ruiz PE, Salazar López CB, Miranda-Díaz AG, Sutto ST, Cardona Muñoz EG, Carvallo-Venegas M, Mendoza-Cabrera S, Mendoza Cerpa CA, Romo-Álvarez C, Arellano-Arteaga KJ, Andrade-Sierra J.   +19 more
europepmc   +1 more source

Preoperative Metabolic Risk Factors and Outcomes in Living Donor Liver Transplant in HBV Recipients. [PDF]

J Clin Med
Koçulu Demir S, Serin A, Bozkurt B, Anılır E, Tokat Y.   +4 more
europepmc   +1 more source

Impact of Donor Volatile Anesthetic Choice on Recipient Post-Reperfusion Syndrome and Clinical Outcomes in Living Donor Liver Transplantation. [PDF]

Int J Mol Sci
Bae HJ, Lee S, Kim KS, Kwon HM, Jun IG, Song JG, Hwang GS.   +6 more
europepmc   +1 more source

Oncologic Outcomes After ABO-Incompatible Versus Compatible Living Donor Liver Transplantation for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. [PDF]

Cancers (Basel)
Kim SH, An BH, Lee JA, Jeong GW.
europepmc   +1 more source

A technical modification in cavo-portal hemi-transposition in adult living donor liver transplantation. [PDF]

Ann Hepatobiliary Pancreat Surg
Makki K, Ghosh NK, Vij V, Srivastava P, Agarwal A, Shekhar A.   +5 more
europepmc   +1 more source